// App-Quantinova.ai

PB1059 : Next-generation FVIII mimetic, Mim8, does not interfere with non-factor VIII haemostasis assays.

Researchers

Presenter

  • A. Bowyer

Principal Investigators

  • K. Hickey

  • S. Kitchen

  • M. Ezban

Medical Centers

  • Department of Coagulation, Sheffield Teaching Hospitals NHSFT, Sheffield, England, United Kingdom

  • Department of Coagulation, Sheffield Teaching Hospitals NHSFT, Sheffield, England, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

  • Novo Nordisk A/S, Måløv, Hovedstaden, Denmark

Locations

  • United Kingdom

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nucleoside diphosphate kinase A

  • Protein S

  • Prothrombin

  • D-dimer

  • Fibrinogen

  • von Willebrand factor

Drug/Treatment

  • FVIII

  • Fibrinogen (IV)

  • Protein C

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved